Bank of America’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-17,877
| Closed | -$2.35M | – | 7111 |
|
|
2020
Q4 | $2.35M | Buy |
17,877
+10,464
| +141% | +$1.38M | ﹤0.01% | 3281 |
|
|
2020
Q3 | $374K | Sell |
7,413
-1,767
| -19% | -$89.1K | ﹤0.01% | 4357 |
|
|
2020
Q2 | $437K | Buy |
9,180
+4,300
| +88% | +$205K | ﹤0.01% | 4201 |
|
|
2020
Q1 | $239K | Sell |
4,880
-1,285
| -21% | -$62.9K | ﹤0.01% | 4450 |
|
|
2019
Q4 | $354K | Sell |
6,165
-6,415
| -51% | -$368K | ﹤0.01% | 4508 |
|
|
2019
Q3 | $453K | Sell |
12,580
-53,308
| -81% | -$1.92M | ﹤0.01% | 4415 |
|
|
2019
Q2 | $2.05M | Buy |
65,888
+62,541
| +1,869% | +$1.94M | ﹤0.01% | 3451 |
|
|
2019
Q1 | $79K | Sell |
3,347
-3,134
| -48% | -$74K | ﹤0.01% | 5241 |
|
|
2018
Q4 | $89K | Buy |
6,481
+4,552
| +236% | +$62.5K | ﹤0.01% | 5238 |
|
|
2018
Q3 | $19K | Buy |
1,929
+1,549
| +408% | +$15.3K | ﹤0.01% | 5778 |
|
|
2018
Q2 | $8K | Buy |
+380
| New | +$8K | ﹤0.01% | 5971 |
|